[Retracted] Bone Marrow Plasma Cytokine Signature Profiles in Severe Aplastic Anemia

Table 1

Clinical and demographic parameters of patients participating in the present study.

Diagnosis	Number	Age (years)	ANC (10^9/L)	Hb (g/L)	Plt(10^9/L)	Ret%	Ret (10^9/L)	Bone marrow karyotype	Therapy	Duration (months)
Untreated SAA	28	40 (11–78)	0.52 ± 0.82	74.39 ± 11.43	15.14 ± 10.44	0.68 ± 0.83	16.59 ± 19.89	Male 46, XY [9]; Female 46, XX [9]	Not treated except for transfusions	2 (1–3)
Recovering SAA	19	26 (15–65)	4.65 ± 3.33	104.68 ± 37.32	77.42 ± 76.72	2.35 ± 1.16	68.42 ± 33.29	Male 46, XY [9]; Female 46, XX [9]	Treated with a combination of ATG and CsA	32 (6–116)

Values are expressed as means ± SDs. Age and duration values are expressed as follows: mid (min–max). ANC: absolute neutrophil count; Hb: hemoglobin; Plt: platelet count; Ret: reticulocyte. Duration of untreated SAA: from the onset of disease to the time of cytokine measurement; duration of recovering SAA: from the onset of ATG therapy to the time of cytokine measurement.